Literature DB >> 34341104

Molecular basis for lipid recognition by the prostaglandin D2 receptor CRTH2.

Heng Liu1, R N V Krishna Deepak2, Anna Shiriaeva3,4, Cornelius Gati3,5, Alexander Batyuk6, Hao Hu7, Uwe Weierstall7, Wei Liu8,9, Lei Wang1, Vadim Cherezov10,4,5, Hao Fan11, Cheng Zhang12.   

Abstract

Prostaglandin D2 (PGD2) signals through the G protein-coupled receptor (GPCR) CRTH2 to mediate various inflammatory responses. CRTH2 is the only member of the prostanoid receptor family that is phylogenetically distant from others, implying a nonconserved mechanism of lipid action on CRTH2. Here, we report a crystal structure of human CRTH2 bound to a PGD2 derivative, 15R-methyl-PGD2 (15mPGD2), by serial femtosecond crystallography. The structure revealed a "polar group in"-binding mode of 15mPGD2 contrasting the "polar group out"-binding mode of PGE2 in its receptor EP3. Structural comparison analysis suggested that these two lipid-binding modes, associated with distinct charge distributions of ligand-binding pockets, may apply to other lipid GPCRs. Molecular dynamics simulations together with mutagenesis studies also identified charged residues at the ligand entry port that function to capture lipid ligands of CRTH2 from the lipid bilayer. Together, our studies suggest critical roles of charge environment in lipid recognition by GPCRs.

Entities:  

Keywords:  CRTH2 (DP2); MD simulations; crystal structure; lipid binding; prostaglandin D2

Mesh:

Substances:

Year:  2021        PMID: 34341104      PMCID: PMC8364189          DOI: 10.1073/pnas.2102813118

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  61 in total

Review 1.  The second PGD(2) receptor CRTH2: structure, properties, and functions in leukocytes.

Authors:  Kinya Nagata; Hiroyuki Hirai
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2003 Aug-Sep       Impact factor: 4.006

2.  The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.

Authors:  Veit J Erpenbeck; Todor A Popov; David Miller; Steven F Weinstein; Sheldon Spector; Baldur Magnusson; Wande Osuntokun; Paul Goldsmith; Markus Weiss; Jutta Beier
Journal:  Pulm Pharmacol Ther       Date:  2016-06-21       Impact factor: 3.410

3.  Ligand binding to human prostaglandin E receptor EP4 at the lipid-bilayer interface.

Authors:  Yosuke Toyoda; Kazushi Morimoto; Ryoji Suno; Shoichiro Horita; Keitaro Yamashita; Kunio Hirata; Yusuke Sekiguchi; Satoshi Yasuda; Mitsunori Shiroishi; Tomoko Shimizu; Yuji Urushibata; Yuta Kajiwara; Tomoaki Inazumi; Yunhon Hotta; Hidetsugu Asada; Takanori Nakane; Yuki Shiimura; Tomoya Nakagita; Kyoshiro Tsuge; Suguru Yoshida; Tomoko Kuribara; Takamitsu Hosoya; Yukihiko Sugimoto; Norimichi Nomura; Miwa Sato; Takatsugu Hirokawa; Masahiro Kinoshita; Takeshi Murata; Kiyoshi Takayama; Masaki Yamamoto; Shuh Narumiya; So Iwata; Takuya Kobayashi
Journal:  Nat Chem Biol       Date:  2018-12-03       Impact factor: 15.040

4.  Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.

Authors:  Jenny M Mjösberg; Sara Trifari; Natasha K Crellin; Charlotte P Peters; Cornelis M van Drunen; Berber Piet; Wytske J Fokkens; Tom Cupedo; Hergen Spits
Journal:  Nat Immunol       Date:  2011-09-11       Impact factor: 25.606

5.  Structures of the Human PGD2 Receptor CRTH2 Reveal Novel Mechanisms for Ligand Recognition.

Authors:  Lei Wang; Dandan Yao; R N V Krishna Deepak; Heng Liu; Qingpin Xiao; Hao Fan; Weimin Gong; Zhiyi Wei; Cheng Zhang
Journal:  Mol Cell       Date:  2018-09-13       Impact factor: 17.970

Review 6.  Targeting the PGD2/CRTH2/DP1 Signaling Pathway in Asthma and Allergic Disease: Current Status and Future Perspectives.

Authors:  Maciej Kupczyk; Piotr Kuna
Journal:  Drugs       Date:  2017-08       Impact factor: 9.546

7.  XFEL structures of the human MT2 melatonin receptor reveal the basis of subtype selectivity.

Authors:  Linda C Johansson; Benjamin Stauch; John D McCorvy; Gye Won Han; Nilkanth Patel; Xi-Ping Huang; Alexander Batyuk; Cornelius Gati; Samuel T Slocum; Chufeng Li; Jessica M Grandner; Shuming Hao; Reid H J Olsen; Alexandra R Tribo; Sahba Zaare; Lan Zhu; Nadia A Zatsepin; Uwe Weierstall; Saïd Yous; Raymond C Stevens; Wei Liu; Bryan L Roth; Vsevolod Katritch; Vadim Cherezov
Journal:  Nature       Date:  2019-04-24       Impact factor: 49.962

8.  Structural basis of ligand recognition at the human MT1 melatonin receptor.

Authors:  Benjamin Stauch; Linda C Johansson; John D McCorvy; Nilkanth Patel; Gye Won Han; Xi-Ping Huang; Cornelius Gati; Alexander Batyuk; Samuel T Slocum; Andrii Ishchenko; Wolfgang Brehm; Thomas A White; Nairie Michaelian; Caleb Madsen; Lan Zhu; Thomas D Grant; Jessica M Grandner; Anna Shiriaeva; Reid H J Olsen; Alexandra R Tribo; Saïd Yous; Raymond C Stevens; Uwe Weierstall; Vsevolod Katritch; Bryan L Roth; Wei Liu; Vadim Cherezov
Journal:  Nature       Date:  2019-04-24       Impact factor: 49.962

9.  Recent developments in CrystFEL.

Authors:  Thomas A White; Valerio Mariani; Wolfgang Brehm; Oleksandr Yefanov; Anton Barty; Kenneth R Beyerlein; Fedor Chervinskii; Lorenzo Galli; Cornelius Gati; Takanori Nakane; Alexandra Tolstikova; Keitaro Yamashita; Chun Hong Yoon; Kay Diederichs; Henry N Chapman
Journal:  J Appl Crystallogr       Date:  2016-03-29       Impact factor: 3.304

10.  Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma.

Authors:  Piotr Kuna; Leif Bjermer; Göran Tornling
Journal:  Drug Des Devel Ther       Date:  2016-08-31       Impact factor: 4.162

View more
  1 in total

Review 1.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.